Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,721 | 80,727 | 350,589 | 53,169 | 11,840 |
| Marketable Securities | 549,213 | 574,035 | 314,901 | 192,701 | 181,939 |
| Receivables | 384 | 89 | 164 | 4,248 | 609 |
| TOTAL | $643,017 | $665,121 | $674,063 | $254,028 | $199,164 |
| Non-Current Assets | |||||
| PPE Net | 18,806 | 16,953 | 15,731 | 16,448 | 16,974 |
| Investments And Advances | 324,534 | 350,585 | 390,503 | 150,054 | 231,365 |
| TOTAL | $343,340 | $367,538 | $406,234 | $166,502 | $248,339 |
| Total Assets | $986,357 | $1,032,659 | $1,080,297 | $420,530 | $447,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,201 | 6,168 | 5,037 | 5,896 | 2,728 |
| Accrued Expenses | 20,655 | 19,864 | 23,425 | 14,160 | 17,409 |
| Other current liabilities | N/A | N/A | 25,379 | N/A | N/A |
| TOTAL | $56,849 | $53,745 | $83,831 | $53,864 | $54,895 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 30,993 | 27,713 | 29,990 | 33,808 | 34,758 |
| Other Non-Current Liabilities | 500 | 1,000 | 1,000 | 0 | 0 |
| TOTAL | $25,030 | $36,645 | $41,493 | $96,319 | $95,026 |
| Total Liabilities | $81,879 | $90,390 | $125,324 | $150,183 | $149,921 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,931 | 76,355 | 75,553 | 63,917 | 63,430 |
| Common Shares | 767 | 763 | 755 | 637 | 632 |
| Retained earnings | -935,241 | -891,252 | -847,178 | -596,235 | -563,878 |
| Other shareholders' equity | 15,186 | 21,983 | 25,030 | 19,717 | 27,168 |
| TOTAL | $904,478 | $942,269 | $954,973 | $270,347 | $297,582 |
| Total Liabilities And Equity | $986,357 | $1,032,659 | $1,080,297 | $420,530 | $447,503 |